| __timestamp | Perrigo Company plc | Teva Pharmaceutical Industries Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 2613100000 | 9216000000 |
| Thursday, January 1, 2015 | 2891500000 | 8296000000 |
| Friday, January 1, 2016 | 3228800000 | 10044000000 |
| Sunday, January 1, 2017 | 2966700000 | 11560000000 |
| Monday, January 1, 2018 | 2900200000 | 10558000000 |
| Tuesday, January 1, 2019 | 3064100000 | 9351000000 |
| Wednesday, January 1, 2020 | 3248100000 | 8933000000 |
| Friday, January 1, 2021 | 2722500000 | 8284000000 |
| Saturday, January 1, 2022 | 2996200000 | 7952000000 |
| Sunday, January 1, 2023 | 2975200000 | 8200000000 |
| Monday, January 1, 2024 | 8480000000 |
Unlocking the unknown
In the ever-evolving pharmaceutical industry, understanding cost dynamics is crucial. From 2014 to 2023, Teva Pharmaceutical Industries Limited and Perrigo Company plc have shown distinct trends in their cost of revenue. Teva's cost of revenue peaked in 2017, reaching approximately 11.56 billion, before experiencing a gradual decline, ending at around 8.2 billion in 2023. This represents a decrease of about 29% over the period. In contrast, Perrigo's cost of revenue remained relatively stable, with a slight increase of around 14% from 2014 to 2023, peaking at 3.25 billion in 2020. These trends highlight Teva's strategic cost management and Perrigo's consistent operational efficiency. As the pharmaceutical landscape continues to shift, these insights provide a window into the financial strategies of two industry giants.
AbbVie Inc. vs Teva Pharmaceutical Industries Limited: Efficiency in Cost of Revenue Explored
AstraZeneca PLC vs Teva Pharmaceutical Industries Limited: Efficiency in Cost of Revenue Explored
Cost Insights: Breaking Down Vertex Pharmaceuticals Incorporated and Teva Pharmaceutical Industries Limited's Expenses
Cost Insights: Breaking Down Regeneron Pharmaceuticals, Inc. and Perrigo Company plc's Expenses
Cost Insights: Breaking Down Teva Pharmaceutical Industries Limited and Intra-Cellular Therapies, Inc.'s Expenses
Cost of Revenue Comparison: Teva Pharmaceutical Industries Limited vs Amneal Pharmaceuticals, Inc.
Cost of Revenue Comparison: Teva Pharmaceutical Industries Limited vs HUTCHMED (China) Limited
Analyzing Cost of Revenue: Teva Pharmaceutical Industries Limited and Dyne Therapeutics, Inc.
Cost of Revenue Comparison: BioMarin Pharmaceutical Inc. vs Perrigo Company plc
Analyzing Cost of Revenue: Halozyme Therapeutics, Inc. and Perrigo Company plc
Cost Insights: Breaking Down Corcept Therapeutics Incorporated and Perrigo Company plc's Expenses
Cost of Revenue Trends: Perrigo Company plc vs Dyne Therapeutics, Inc.